ALC.SW
Alcon Inc. News
Sign up for free!
Get instant access to all of our market news and analysis with our free REST API.
Latest news
Live response for past 24 hours
{
"meta": {
"found": 9,
"returned": 9,
"limit": 10,
"page": 1
},
"data": [
{
"uuid": "4cf1494f-41cf-4bf7-85e1-85927fbcbe86",
"title": "Q1 2024 Alcon AG Earnings Call Transcript",
"description": "May 14, 2024 / 12:00PM GMTOperator Greetings, and welcome to the Alcon's First Quarter 2024 Earnings Call. (Operator Instructions) As a reminder, this conferenc",
"keywords": "GuruFocus, Article, News, GuruFocus Research, NYSE:ALC",
"snippet": "May 14, 2024 / 12:00PM GMT\n\nOperator\n\n\n\nGreetings, and welcome to the Alcon's First Quarter 2024 Earnings Call. (Operator Instructions) As a reminder, this conf...",
"url": "https://www.gurufocus.com/news/2437873/q1-2024-alcon-ag-earnings-call-transcript",
"image_url": "https://static.gurufocus.com/images/global_logo_twitter_card.png",
"language": "en",
"published_at": "2024-05-15T05:07:07.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "ALC.SW",
"name": "Alcon Inc.",
"exchange": null,
"exchange_long": null,
"country": "ch",
"type": "equity",
"industry": "Healthcare",
"match_score": 61.971115,
"sentiment_score": 0.2294,
"highlights": [
{
"highlight": "Daniel Cravens - <em>Alcon</em> <em>Inc</em>. - VP of IR\n\n\n\nWelcome to Alcon's First Quarter 2024 Earnings Conference Call. Today, we issued a press release and interim financial report and posted a supplemental slide presentation on our website to enhance today's call.",
"sentiment": 0.4588,
"highlighted_in": "main_text"
},
{
"highlight": "Q1 2024 <em>Alcon</em> AG Earnings Call Transcript",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
],
"similar": []
},
{
"uuid": "a6ee376b-d9a1-49e1-b4db-8e3e0c69f465",
"title": "Unveiling Alcon (ALC)'s Value: Is It Really Priced Right? A Comprehensive Guide",
"description": "Alcon Inc (ALC) recently showcased a significant daily gain of 10.69%, with a three-month gain of 17.18%. With an Earnings Per Share (EPS) of 1.96, investors an",
"keywords": "GuruFocus, Article, News, GuruFocus Research, ALC",
"snippet": "Alcon Inc (ALC, Financial) recently showcased a significant daily gain of 10.69%, with a three-month gain of 17.18%. With an Earnings Per Share (EPS) of 1.96, i...",
"url": "https://www.gurufocus.com/news/2437794/unveiling-alcon-alcs-value-is-it-really-priced-right-a-comprehensive-guide",
"image_url": "https://static.gurufocus.com/logos/0C0000BM5H.png?13",
"language": "en",
"published_at": "2024-05-15T01:14:48.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "ALC.SW",
"name": "Alcon Inc.",
"exchange": null,
"exchange_long": null,
"country": "ch",
"type": "equity",
"industry": "Healthcare",
"match_score": 47.323467,
"sentiment_score": 0.587422,
"highlights": [
{
"highlight": "<em>Alcon</em> <em>Inc</em> (ALC, Financial) recently showcased a significant daily gain of 10.69%, with a three-month gain of 17.18%. With an Earnings Per Share (EPS) of 1.96, investors and analysts are keen to determine if the stock is fairly valued.",
"sentiment": 0.9349,
"highlighted_in": "main_text"
},
{
"highlight": "This analysis delves into the intrinsic valuation of <em>Alcon</em>, leveraging the unique GF Value to ascertain whether its current market price reflects its true worth.\n\nCompany Overview\n\n<em>Alcon</em>, a leader in the vision care industry, was spun off from Novartis in April 2019 and operates through two main segments: vision care and surgical.",
"sentiment": 0.9382,
"highlighted_in": "main_text"
},
{
"highlight": "With a robust market presence and a significant installed base of surgical equipment worldwide, <em>Alcon</em> continues to be a pivotal player in eye health solutions.",
"sentiment": 0.5994,
"highlighted_in": "main_text"
},
{
"highlight": "This alignment suggests that <em>Alcon</em> is fairly valued, implying that the stock price may move in tandem with the company's business growth.\n\nFinancial Strength and Stability\n\nInvestors must consider the financial strength of a company before investing, as it reflects the risk associated with potential capital loss.",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Alcon</em> has shown profitability over the past decade, with an operating margin of 11.93%, ranking better than 69.58% of its industry peers. Additionally, the company's average annual revenue growth rate of 9.9% is commendable, surpassing over half of its competitors in the Medical Devices & Instruments industry.",
"sentiment": 0.765,
"highlighted_in": "main_text"
},
{
"highlight": "When comparing the Return on Invested Capital (ROIC) of 4.63 to the Weighted Average Cost of Capital (WACC) of 6.75, it's evident that <em>Alcon</em> is currently not generating returns above its cost of capital, which could be a concern for value creation.",
"sentiment": 0.5423,
"highlighted_in": "main_text"
},
{
"highlight": "Conclusion\n\nIn conclusion, <em>Alcon</em> appears to be fairly valued based on its current market price and GF Value. The company's financial health is stable, albeit with some concerns regarding debt levels.",
"sentiment": 0.6124,
"highlighted_in": "main_text"
},
{
"highlight": "For more detailed financial insights and to explore Alcon's historical financial performance, visit the 30-Year Financials of <em>Alcon</em>.\n\nTo discover other high-quality companies that might offer above-average returns at reduced risk, consider using the GuruFocus High Quality Low Capex Screener.",
"sentiment": -0.4939,
"highlighted_in": "main_text"
},
{
"highlight": "Unveiling <em>Alcon</em> (ALC)'s Value: Is It Really Priced Right? A Comprehensive Guide",
"sentiment": 0.5709,
"highlighted_in": "title"
}
]
}
],
"similar": []
},
{
"uuid": "5ed49675-7ede-430a-9e4a-a1002cf7da56",
"title": "Alcon stock price target raised on robust growth By Investing.com",
"description": "Alcon stock price target raised on robust growth",
"keywords": "",
"snippet": "On Tuesday, Stifel has increased its price target for Alcon Inc. (NYSE: NYSE: ) shares to $100.00, up from the previous $95.00, while reiterating a Buy rating o...",
"url": "https://www.investing.com/news/company-news/alcon-stock-price-target-raised-on-robust-growth-93CH-3440769",
"image_url": "https://i-invdn-com.investing.com/news/news_six_pile_69x52._800x533_L_1419494215.jpg",
"language": "en",
"published_at": "2024-05-14T21:42:49.000000Z",
"source": "investing.com",
"relevance_score": null,
"entities": [
{
"symbol": "ALC.SW",
"name": "Alcon Inc.",
"exchange": null,
"exchange_long": null,
"country": "ch",
"type": "equity",
"industry": "Healthcare",
"match_score": 57.020805,
"sentiment_score": 0.553633,
"highlights": [
{
"highlight": "On Tuesday, Stifel has increased its price target for <em>Alcon</em> <em>Inc</em>. (NYSE: NYSE: ) shares to $100.00, up from the previous $95.00, while reiterating a Buy rating on the stock. This adjustment follows Alcon's first-quarter results for 2024, which the firm described as solid despite foreign exchange headwinds.",
"sentiment": 0.5994,
"highlighted_in": "main_text"
},
{
"highlight": "In conclusion, Stifel's analysis suggests that <em>Alcon</em> should be considered a core investment. The firm's conviction in Alcon's long-term growth potential is reflected in the raised price target, signaling increased confidence in the company's trajectory moving forward.\n\nhere or remove ads . 3rd party Ad.",
"sentiment": 0.8658,
"highlighted_in": "main_text"
},
{
"highlight": "See disclosureor\n\nInvestingPro Insights\n\n<em>Alcon</em> <em>Inc</em>. (NYSE: ALC) has demonstrated a robust financial performance, with real-time data from InvestingPro showing a market capitalization of $44.03 billion and a notable revenue growth of 8.47% over the last twelve months as of Q4 2023.",
"sentiment": 0.6124,
"highlighted_in": "main_text"
},
{
"highlight": "With a P/E ratio of 41.63 and a PEG ratio of 0.22, <em>Alcon</em> is trading at a valuation that reflects its near-term earnings growth potential, as noted in one of the InvestingPro Tips.",
"sentiment": 0.3818,
"highlighted_in": "main_text"
},
{
"highlight": "For investors seeking a comprehensive analysis, InvestingPro offers additional insights, including a total of 13 InvestingPro Tips for <em>Alcon</em>, which can be further explored at https://www.investing.com/pro/ALC.",
"sentiment": 0.25,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Alcon</em> stock price target raised on robust growth By Investing.com",
"sentiment": 0.6124,
"highlighted_in": "title"
}
]
}
],
"similar": []
},
{
"uuid": "05292b66-cb31-4eeb-8530-adcb90eda1be",
"title": "Why Alibaba Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session - Alibaba Gr Holding (NYSE:BABA)",
"description": "",
"keywords": "",
"snippet": "Loading... Loading...\n\nShares of Alibaba Group Holding Limited BABA fell sharply during Tuesday's session following mixed first-quarter financial results.\n\nThe ...",
"url": "https://www.benzinga.com/news/24/05/38824322/why-alibaba-shares-are-trading-lower-by-around-7-here-are-other-stocks-moving-in-tuesdays-mid-day-se",
"image_url": "https://cdn.benzinga.com/files/images/story/2024/05/14/alibaba-logo.jpeg?width=1200&height=800&fit=crop",
"language": "en",
"published_at": "2024-05-14T17:30:43.000000Z",
"source": "benzinga.com",
"relevance_score": null,
"entities": [
{
"symbol": "ALC.SW",
"name": "Alcon Inc.",
"exchange": null,
"exchange_long": null,
"country": "ch",
"type": "equity",
"industry": "Healthcare",
"match_score": 13.076921,
"sentiment_score": 0.9313,
"highlights": [
{
"highlight": "<em>Alcon</em> <em>Inc</em> . ALC gained 9.6% to $88.47 following better-than-expected first-quarter earnings.\n\n. gained 9.6% to $88.47 following better-than-expected first-quarter earnings. Tilray Brands, Inc. TLRY shares rose 9.6% to $2.18.\n\nshares rose 9.6% to $2.18. Bloom Energy Corporation BE gained 9.5% to $12.65.\n\ngained 9.5% to $12.65. Rent the Runway, Inc.",
"sentiment": 0.9313,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
},
{
"uuid": "3dd2e592-3195-4d12-a918-e79a49f80fbe",
"title": "Alcon Inc's Meteoric Rise: Unpacking the 16% Surge in Just 3 Months",
"description": "Alcon Inc (ALC), a prominent player in the medical devices and instruments industry, has demonstrated a remarkable stock performance recently. Over the past wee",
"keywords": "GuruFocus, Article, News, GuruFocus Research, ALC, XSWX:STMN, XSWX:YPSN, XSWX:TECN",
"snippet": "Alcon Inc (ALC, Financial), a prominent player in the medical devices and instruments industry, has demonstrated a remarkable stock performance recently. Over t...",
"url": "https://www.gurufocus.com/news/2437295/alcon-incs-meteoric-rise-unpacking-the-16-surge-in-just-3-months",
"image_url": "https://static.gurufocus.com/images/global_logo_twitter_card.png",
"language": "en",
"published_at": "2024-05-14T16:17:28.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "ALC.SW",
"name": "Alcon Inc.",
"exchange": null,
"exchange_long": null,
"country": "ch",
"type": "equity",
"industry": "Healthcare",
"match_score": 57.49701,
"sentiment_score": 0.701909,
"highlights": [
{
"highlight": "<em>Alcon</em> <em>Inc</em> (ALC, Financial), a prominent player in the medical devices and instruments industry, has demonstrated a remarkable stock performance recently. Over the past week, the company's stock price has surged by 9.91%, and over the last three months, it has seen an impressive increase of 16.42%.",
"sentiment": 0.8885,
"highlighted_in": "main_text"
},
{
"highlight": "Currently, <em>Alcon</em> boasts a market capitalization of $44.26 billion. According to GuruFocus's valuation metrics, <em>Alcon</em> is fairly valued with a GF Value of $89.41, aligning closely with its current price of $88.54. This valuation is consistent with three months ago, maintaining its status as fairly valued.",
"sentiment": 0.802,
"highlighted_in": "main_text"
},
{
"highlight": "Introduction to <em>Alcon</em> <em>Inc</em>\n\n<em>Alcon</em> <em>Inc</em>, established following a spin-off from Novartis in April 2019, has quickly ascended to a leadership position in the vision care sector. The company operates through two main segments: Vision Care and Surgical.",
"sentiment": 0.8555,
"highlighted_in": "main_text"
},
{
"highlight": "Growth Trajectory of <em>Alcon</em>\n\nAlcon's growth metrics are robust, with a Growth Rank of 8/10, indicating strong future potential. The company has shown a consistent increase in revenue, with a 9.90% growth rate over the past three years, surpassing 56.43% of its industry counterparts.",
"sentiment": 0.9468,
"highlighted_in": "main_text"
},
{
"highlight": "Looking ahead, <em>Alcon</em> is projected to maintain a healthy growth trajectory with an estimated 12.80% EPS growth rate over the next three to five years. These projections suggest a promising future for <em>Alcon</em> in terms of revenue and earnings per share growth.",
"sentiment": 0.9246,
"highlighted_in": "main_text"
},
{
"highlight": "Other notable shareholders include PRIMECAP Management (Trades, Portfolio) and Ken Fisher (Trades, Portfolio), holding significant stakes and underscoring the investment appeal of <em>Alcon</em> in the healthcare sector.",
"sentiment": 0.2023,
"highlighted_in": "main_text"
},
{
"highlight": "Competitive Landscape\n\nWhen compared to its primary competitors like Straumann Holding AG and Ypsomed Holding AG, <em>Alcon</em> stands out with a significantly larger market capitalization of $44.26 billion.",
"sentiment": 0.4939,
"highlighted_in": "main_text"
},
{
"highlight": "This size advantage could offer <em>Alcon</em> greater resources for research, development, and market expansion, potentially leading to sustained growth and market dominance in the medical devices and instruments industry.",
"sentiment": 0.7845,
"highlighted_in": "main_text"
},
{
"highlight": "Conclusion: Alcon's Strategic Market Position\n\n<em>Alcon</em> <em>Inc</em> has established a strong market presence characterized by consistent growth and profitability. With a solid track record and positive growth forecasts, <em>Alcon</em> represents a stable investment opportunity in the medical devices sector.",
"sentiment": 0.9571,
"highlighted_in": "main_text"
},
{
"highlight": "Investors looking for exposure to healthcare and technology-driven growth may find <em>Alcon</em> an attractive option, supported by its innovative product lines and strategic market positioning.\n\nThis article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice.",
"sentiment": 0.8658,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Alcon</em> Inc's Meteoric Rise: Unpacking the 16% Surge in Just 3 Months",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
],
"similar": []
},
{
"uuid": "a355ac97-a135-41eb-85cf-cee573885388",
"title": "Sony Group Posts Upbeat Earnings, Joins GameStop, Paysafe And Other Big Stocks Moving Higher On Tuesday - Sony Group (NYSE:SONY)",
"description": "",
"keywords": "",
"snippet": "Loading... Loading...\n\nU.S. stocks were higher, with the Dow Jones gaining around 20 points on Tuesday.\n\nShares of Sony Group Corporation SONY rose sharply duri...",
"url": "https://www.benzinga.com/news/24/05/38819873/sony-group-posts-upbeat-earnings-joins-gamestop-paysafe-and-other-big-stocks-moving-higher-on-tuesda",
"image_url": "https://cdn.benzinga.com/files/images/story/2024/05/14/Image47.jpeg?width=1200&height=800&fit=crop",
"language": "en",
"published_at": "2024-05-14T15:01:34.000000Z",
"source": "benzinga.com",
"relevance_score": null,
"entities": [
{
"symbol": "ALC.SW",
"name": "Alcon Inc.",
"exchange": null,
"exchange_long": null,
"country": "ch",
"type": "equity",
"industry": "Healthcare",
"match_score": 15.788391,
"sentiment_score": 0.5719,
"highlights": [
{
"highlight": "<em>Alcon</em> <em>Inc</em> . ALC rose 9.6% to $88.47 following better-than-expected first-quarter earnings.\n\n. rose 9.6% to $88.47 following better-than-expected first-quarter earnings. Bloom Energy Corporation BE rose 9.5% to $12.65.\n\nrose 9.5% to $12.65. Recursion Pharmaceuticals, Inc . RXRX gained 8.8% to $10.32.",
"sentiment": 0.5719,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
},
{
"uuid": "a18641e0-d2a3-42d2-8d13-c8257ad6fc4c",
"title": "Alcon Inc. (ALC) Q1 2024 Earnings Call Transcript",
"description": "Alcon Inc. (NYSE:NYSE:ALC) Q1 2024 Earnings Conference Call May 14, 2024 8:00 AM ETCompany ParticipantsDan Cravens - Vice President, Investor RelationsDavid...",
"keywords": "",
"snippet": "Alcon Inc. (NYSE:ALC) Q1 2024 Earnings Conference Call May 14, 2024 8:00 AM ET\n\nCompany Participants\n\nDan Cravens - Vice President, Investor Relations\n\nDavid En...",
"url": "https://seekingalpha.com/article/4693088-alcon-inc-alc-q1-2024-earnings-call-transcript",
"image_url": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
"language": "en",
"published_at": "2024-05-14T14:48:08.000000Z",
"source": "seekingalpha.com",
"relevance_score": null,
"entities": [
{
"symbol": "ALC.SW",
"name": "Alcon Inc.",
"exchange": null,
"exchange_long": null,
"country": "ch",
"type": "equity",
"industry": "Healthcare",
"match_score": 101.90227,
"sentiment_score": 0.50258,
"highlights": [
{
"highlight": "<em>Alcon</em> <em>Inc</em>.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "With this potential acquisition, <em>Alcon</em> will further our commitment to the glaucoma space and pioneer the expansion of interventional glaucoma globally with the Eagle device. We expect the transaction to close during the third quarter, and we look forward to welcoming the Belkin Associates to the <em>Alcon</em> family.",
"sentiment": 0.6705,
"highlighted_in": "main_text"
},
{
"highlight": "Finally, I want to thank the entire <em>Alcon</em> team for a great start to 2024. With that, I'll turn it back to David.\n\nDavid Endicott\n\nThanks, Tim. To conclude my remarks, I want to thank the team once again for a strong start to the year.",
"sentiment": 0.9423,
"highlighted_in": "main_text"
},
{
"highlight": "We've got a number of growth drivers and a position at <em>Alcon</em> nicely to expand sales faster than our markets, deliver operating leverage, and long-term shareholder value.\n\nWith that, let's open the line for Q&A.\n\nQuestion-and-Answer Session\n\nOperator\n\nThank you. At this time, we will be conducting a question-and-answer session.",
"sentiment": 0.9001,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Alcon</em> <em>Inc</em>. (ALC) Q1 2024 Earnings Call Transcript",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
],
"similar": []
},
{
"uuid": "405d7167-20bb-4354-afcc-1df754f25713",
"title": "Le azioni Alcon mantengono il rating Buy grazie alle prospettive di crescita Da Investing.com",
"description": "Le azioni Alcon mantengono il rating Buy grazie alle prospettive di crescita",
"keywords": "",
"snippet": "Martedì scorso, Alcon Inc. (ALC:SW) (NYSE: ALC), leader nei prodotti per la cura degli occhi, ha ricevuto la conferma del rating Buy e dell'obiettivo di prezzo...",
"url": "https://it.investing.com/news/company-news/le-azioni-alcon-mantengono-il-rating-buy-grazie-alle-prospettive-di-crescita-93CH-2369127",
"image_url": "https://i-invdn-com.investing.com/news/news_pile_69x52._800x533_L_1419494209.jpg",
"language": "it",
"published_at": "2024-05-14T13:40:19.000000Z",
"source": "it.investing.com",
"relevance_score": null,
"entities": [
{
"symbol": "ALC.SW",
"name": "Alcon Inc.",
"exchange": null,
"exchange_long": null,
"country": "ch",
"type": "equity",
"industry": "Healthcare",
"match_score": 51.27166,
"sentiment_score": null,
"highlights": [
{
"highlight": "Martedì scorso, <em>Alcon</em> <em>Inc</em>. (ALC:SW) (NYSE: ALC), leader nei prodotti per la cura degli occhi, ha ricevuto la conferma del rating Buy e dell'obiettivo di prezzo di CHF 87,00 da parte di CFRA, un'importante società di ricerca finanziaria.",
"sentiment": 0.296,
"highlighted_in": "main_text"
},
{
"highlight": "La previsione della società si basa su un rapporto prezzo/utili (P/E) di 32 volte per l'anno 2024, allineato alle medie storiche di <em>Alcon</em>.\n\n<em>Alcon</em> ha alzato le sue previsioni di crescita delle vendite e degli utili per azione (EPS) a valuta costante per l'intero 2024 rispettivamente al 7%-9% e al 15%-18%, rispetto ai precedenti 6%-8% e 13%-16%.",
"sentiment": 0.296,
"highlighted_in": "main_text"
},
{
"highlight": "Inoltre, <em>Alcon</em> ha registrato un miglioramento del margine operativo core di 1,4 punti percentuali, attribuito a una migliore leva operativa e alla tempistica delle spese discrezionali.",
"sentiment": 0.296,
"highlighted_in": "main_text"
},
{
"highlight": "Le previsioni di CFRA per la crescita delle vendite di <em>Alcon</em> rimangono intorno al 5%-6% sia per il 2024 che per il 2025, con aspettative di aumento del margine operativo di base tra il 20,5% e il 22,0%, rispetto al 19,7% del 2023.",
"sentiment": 0.296,
"highlighted_in": "main_text"
},
{
"highlight": "Le stime di EPS della società sono fissate a 3,00 dollari per il 2024 e a 3,40 dollari per il 2025, che si collocano all'estremità inferiore dell'intervallo di riferimento di <em>Alcon</em> per il 2024.\n\nqui o rimuovere gli annunci . Annuncio di terzi. Non è un'offerta o una raccomandazione di Investing.com.",
"sentiment": 0.296,
"highlighted_in": "main_text"
},
{
"highlight": "Consultare l'informativa\n\nApprofondimenti di InvestingPro\n\n<em>Alcon</em> <em>Inc</em>. (ALC:SW) (NYSE: ALC) è stata oggetto di interesse dopo il rating Buy di CFRA e le ottimistiche prospettive finanziarie della società.",
"sentiment": 0.296,
"highlighted_in": "main_text"
},
{
"highlight": "Analizzando i dati in tempo reale di InvestingPro, la capitalizzazione di mercato di <em>Alcon</em> è di 40,36 miliardi di dollari, a testimonianza della sua significativa presenza nel settore della cura degli occhi.",
"sentiment": 0.296,
"highlighted_in": "main_text"
},
{
"highlight": "Il rapporto P/E, un parametro chiave evidenziato da CFRA, è attualmente pari a 38,82, leggermente superiore alla previsione di CFRA di 32 per il 2024, indicando potenzialmente un premio che gli investitori sono disposti a pagare per le prospettive di crescita di <em>Alcon</em>.",
"sentiment": 0.296,
"highlighted_in": "main_text"
},
{
"highlight": "Per coloro che desiderano approfondire lo stato di salute finanziaria di <em>Alcon</em>, InvestingPro offre una serie di ulteriori suggerimenti: ne sono disponibili altri 10, accessibili con un abbonamento.",
"sentiment": 0.296,
"highlighted_in": "main_text"
},
{
"highlight": "Con una crescita dei ricavi dell'8,47% negli ultimi dodici mesi a partire dal quarto trimestre del 2023, <em>Alcon</em> sta dimostrando la sua capacità di espandere efficacemente la propria linea di business.",
"sentiment": 0.296,
"highlighted_in": "main_text"
},
{
"highlight": "Le azioni <em>Alcon</em> mantengono il rating Buy grazie alle prospettive di crescita Da Investing.com",
"sentiment": 0.296,
"highlighted_in": "title"
}
]
}
],
"similar": []
},
{
"uuid": "5eedec0f-0c59-457c-b912-218b251b1f3d",
"title": "Why Alcon Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket - Alcon (NYSE:ALC)",
"description": "",
"keywords": "",
"snippet": "Loading... Loading...\n\nShares of Alcon Inc. ALC rose sharply in today's pre-market trading following better-than-expected first-quarter earnings.\n\nAlcon posted ...",
"url": "https://www.benzinga.com/news/24/05/38814828/why-alcon-shares-are-trading-higher-by-over-10-here-are-20-stocks-moving-premarket",
"image_url": "https://cdn.benzinga.com/files/images/story/2024/05/14/xrdDAFinCU7viM2-j4467771911-t23051112.jpeg?width=1200&height=800&fit=crop",
"language": "en",
"published_at": "2024-05-14T12:30:32.000000Z",
"source": "benzinga.com",
"relevance_score": null,
"entities": [
{
"symbol": "ALC.SW",
"name": "Alcon Inc.",
"exchange": null,
"exchange_long": null,
"country": "ch",
"type": "equity",
"industry": "Healthcare",
"match_score": 55.88745,
"sentiment_score": 0.476133,
"highlights": [
{
"highlight": "Shares of <em>Alcon</em> <em>Inc</em>. ALC rose sharply in today's pre-market trading following better-than-expected first-quarter earnings.\n\n<em>Alcon</em> posted adjusted earnings of 78 cents per share, beating market expectations of 63 cents per share.",
"sentiment": 0.3818,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Alcon</em> shares jumped 10.8% to $89.40 in the pre-market trading session.\n\nHere are some other stocks moving in pre-market trading.\n\nGainers\n\nGameStop Corp . GME gained 40.2% to $42.70 in pre-market trading after jumping over 74% on Monday.\n\n. gained 40.2% to $42.70 in pre-market trading after jumping over 74% on Monday.",
"sentiment": 0.7506,
"highlighted_in": "main_text"
},
{
"highlight": "Why <em>Alcon</em> Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket - <em>Alcon</em> (NYSE:ALC)",
"sentiment": 0.296,
"highlighted_in": "title"
}
]
}
],
"similar": []
}
]
}
Sentiment
Live response for past 24 hours
{
"meta": {
"returned": 1,
"limit": 10
},
"data": [
{
"key": "ALC.SW",
"total_documents": 9,
"sentiment_avg": 0.5692846197634935
}
]
}
Other details
Exchange
- SIX Swiss Exchange
- equity
- Healthcare
- ch